HER2 also has emerged as a validated target for CAR-T therapy, with recent reports indicating its overexpression in colorectal cancer, thus presenting a potential therapeutic avenue for colorectal cancer treatment (38). The gene discussed is ERBB2; the disease is colorectal cancer.